BTAI (BioXcel) Net earnings per share (EPS TTM)

BioXcel (BTAI) - corporate logo

BioXcel Therapeutics (BTAI) is implementing neural networks to rapidly identify new applications for existing medications. The company focuses on psychosis therapy, offering the drug IGALMI to clinics to assist patients with dementia. Currently, the business is developing the commercial launch of a treatment for acute agitation in bipolar disorders. Serving as the primary valuation tool, this price chart demonstrates an EPS TTM of 66.40.

BioXcel - BTAI Earnings per share for the last twelve months (period 02/11/2024 - 09/19/2026)

BTAI (BioXcel Therapeutics Inc): analytical breakdowns and indicator data

- price and consensus price forecast:
Fundamental company valuation:BTAI BioXcel
Flagship merchandise of BioXcel Therapeutics, Inc.

Analyzing profit resilience during stress phases is critical for long-term risk management, measured via the dynamics of trailing twelve-month earnings per share. The current EPS TTM YoY growth rate reflects the ability of BioXcel Therapeutics (BTAI) to monetize its AI patents under strict FDA oversight, determining the business's actual margin of safety amidst a high regulatory burden.

Direct competitors

Net earnings per one share for the last twelve months Jazz Pharma|CYTK (Cytokinetics Inc.) - Net earnings per share for the last 12 months|PTC Bio (PTCT) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Scholar Rock|CNTA: Earnings per share for the trailing year|Earnings per share for the last twelve months Dyne Therapeutics (DYN)|EWTX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Rapport Pharma RAPP|Alumis Pharma - Earnings per share for the last twelve months|ZVRA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Contineum Therapeutics, Inc.|LRMR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Capricor Therapeutics CAPR|Net earnings per share for the last 12 months TRDA|Net earnings per one share for the last twelve months Channel PTHS|Earnings per share for the last twelve months MediciNova Inc. (MNOV)|SER - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months ProMIS Neurosciences, Inc. PMN|APUS (Apimeds) - Earnings per one share for the last 12 months|AEON - Earnings per share for the last twelve months|Net earnings per share for the last four quarters NLS Pharmaceutics Ltd. NLSP|Bionomics Limited (BNOX) - Earnings per share for the last twelve months|fsdpharma.com - Earnings per share for the trailing year|RETA (reatapharma.com) - Net earnings per share (EPS TTM)